More early retirements at Mitsubishi Tanabe
This article was originally published in Scrip
Another 217 people at Mitsubishi Tanabe Pharma(MTP) in Japan are to take early retirement from the company on September 30th. The option was offered to all employees aged between 40 and less than 60 who had been with the firm (or its pre-merger predecessors) for over 10 years. Those taking it up will receive special allowances and support in addition to standard retirement benefits, for which MTP said it would book ¥3.9 billion ($35.9 million) in one-off costs in the second quarter ending September 30th. There had already been several similar rounds of employee reductions as part of MTP's creation from the merger of Mitsubishi Pharma and Tanabe, completed last October.
You may also be interested in...
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.